The Female Health Co. receives FDA approval for new female contraceptive

CHICAGO The Female Health Company announced Wednesday that its FC2 Female Condom received approval from the Food and Drug Administration.

The FC2 is a woman-initiated barrier method that helps to protect against sexually transmitted infections (STIs), HIV/AIDS and unintended pregnancy.

FHC's lower-cost second generation female condom will now be available for purchase and distribution in the United States. FDA approval also will enable the United States Agency for International Development to procure FC2 for distribution to global HIV/AIDS programs.